Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal

11 hours ago 1
Eli Lilly signed a collaboration and licensing statement worthy up to $1.9 cardinal with Ascidian Therapeutics to probe and make kidney-disease treatments.
Read Entire Article